Crispr Therapeutics AG (CRSP) Receives a Buy from Chardan Capital
In a report released yesterday, Geulah Livshits from Chardan Capital maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research ...
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...
The ‘nice’ CEO is no longer en vogue as business pressures reshape leadership styles
CEOs like Elon Musk and Mark Zuckerberg are adopting aspects of Jack Welch's high-intensity, performance-focused management ...